KID31 and antibodies that bind thereto
US8313916B2 · kind B2 · utility
0Cited by
22References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 2010 |
| Grant date | Nov 20, 2012 |
| Priority date | — |
| Expiry date | Oct 29, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides the identification and characterization of a disease and cancer-associated antigen, KID31. The invention also provides modulators of KID31, including a family of monoclonal antibodies that bind to antigen KID31, and methods of diagnosing and treating various human cancers and diseases with KID31.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.